Jason T Kropp

US Patent:

20120184568, Jul 19, 2012

Filed:

Jan 10, 2012

Appl. No.:

13/347423

Inventors:

Pingda Ren - San Diego CA, US
Michael Martin - San Marcos CA, US
Paul Isbester - Castleton NY, US
Benjamin S. Lane - Lynnfield MA, US
Jason Kropp - Westford MA, US

International Classification:

A61K 31/52
A61P 35/00
A61P 29/00
C07D 475/06

US Classification:

51426322, 544277

Abstract:

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.

US Patent:

20230108157, Apr 6, 2023

Filed:

Mar 21, 2022

Appl. No.:

17/699582

Inventors:

- Cambridge MA, US
Michael Martin - San Marcos CA, US
Paul Isbester - Castleton NY, US
Benjamin S. Lane - Lynnfield MA, US
Jason Kropp - Westford MA, US

International Classification:

C07D 473/34
A61P 35/00
A61P 29/00

Abstract:

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.

US Patent:

20200385388, Dec 10, 2020

Filed:

Jan 3, 2020

Appl. No.:

16/734135

Inventors:

- Cambridge MA, US
Michael Martin - San Marcos CA, US
Paul Isbester - Castleton NY, US
Benjamin S. Lane - Lynnfield MA, US
Jason Kropp - Westford MA, US

International Classification:

C07D 473/34
A61P 35/00
A61P 29/00

Abstract:

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.

US Patent:

20180273535, Sep 27, 2018

Filed:

Oct 31, 2017

Appl. No.:

15/799612

Inventors:

- Cambridge MA, US
Michael Martin - San Marcos CA, US
Paul Isbester - Castleton NY, US
Benjamin S. Lane - Lynnfield MA, US
Jason Kropp - Westford MA, US

International Classification:

C07D 473/34

Abstract:

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including Pl3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.

US Patent:

20160152619, Jun 2, 2016

Filed:

Feb 4, 2016

Appl. No.:

15/016117

Inventors:

- Cambridge MA, US
Michael MARTIN - San Marcos CA, US
Paul ISBESTER - Castleton NY, US
Benjamin S. LANE - Lynnfield MA, US
Jason KROPP - Westford MA, US

International Classification:

C07D 473/34

Abstract:

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.

US Patent:

20140371450, Dec 18, 2014

Filed:

Jul 9, 2014

Appl. No.:

14/327499

Inventors:

- Cambridge MA, US
Michael MARTIN - San Marcos CA, US
Paul ISBESTER - Castleton NY, US
Benjamin S. LANE - Lynnfield MA, US
Jason KROPP - Westford MA, US

International Classification:

C07D 473/34

US Classification:

544277

Abstract:

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.